FIELD: pharmacology.
SUBSTANCE: antiviral drug is made as a hard gelatin capsule containing granules comprising oseltamivir phosphate as an active ingredient and auxiliary additives: microcrystalline cellulose or lactose, povidone, aerosil, crospovidone or croscarmellose, sodium stearyl fumarate at a certain ratio of components. The method for antiviral drug production is implemented by wet granulation.
EFFECT: invention allows preparation of an antiviral drug based on oseltamivir that quickly and completely releases the active substance, and is stable during storage.
4 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| DRUG PREPARATION IN FORM OF CAPSULES EXHIBITING ANTIVIRAL AND INTERFERONOGENIC ACTION | 2010 |
|
RU2446803C1 |
| NEW COMBINED PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT FOR TREATMENT OF CORONAVIRUS INFECTION | 2022 |
|
RU2806643C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | 2021 |
|
RU2780252C1 |
| ANTIVIRAL AND IMMUNOSTIMULATING DRUG | 2015 |
|
RU2593570C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| PHARMACEUTICAL COMPOSITION 1-[2-(1-METHYLIMIDAZOL-4-YL)-ETHYL]PERHYDROAZINE-2,6-DIONE FOR THERAPY OF RESPIRATORY DISEASES | 2021 |
|
RU2823588C2 |
| PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
| SOLID DRUG FORM OF INDINAVIR WITH IMMEDIATE RELEASE AND METHOD OF OBTAINING THEREOF | 2016 |
|
RU2616267C1 |
| ANTI-COVID-19 (SARS-COV-2) VIRAL PHARMACEUTICAL COMPOSITION | 2020 |
|
RU2731932C1 |
